Projects funded by the NCN

New benzo[b]furane and dicarboximide derivatives with anticancer activity- studies on the mechanism of action in human c...

Call: PRELUDIUM 3 , Panel: NZ7

Principal investigator: Karolina Królewska

Centrum Badań Molekularnych i Makromolekularnych PAN

LCAP biomimetics - alicyclic amine derivatives as a new class of monoaminergic receptor ligands

Call: OPUS 3 , Panel: NZ7

Principal investigator: dr hab. Paweł Maria Zajdel

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Computational Risk Assessment of ionic liquids Before their use in new technologies (CRAB)

Call: SONATA BIS 1 , Panel: NZ7

Principal investigator: dr hab. Tomasz Puzyn

Uniwersytet Gdański

Search for new "drug-like" molecules designed as adenosine receptors ligands

Call: HARMONIA 2 , Panel: NZ4

Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Exploring Antimicrobial Potential of Mytilus Genomic Resources

Call: OPUS 29 , Panel: NZ8

Principal investigator: prof. Artur Stanisław Burzyński

Instytut Oceanologii PAN

Could the new diagnostic methods be useful in opimalizing the choice of treatment of asymptomatic patients with signific...

Call: OPUS 2 , Panel: NZ7

Principal investigator: dr hab. Ewa Hanna Orłowska-Baranowska

Instytut Kardiologii im. Prymasa Tysiąclecia Stefana Kardynała Wyszyńskiego

Nature as an unlimited and renewable source of photoinitiators for 3D Printingsynthesisand spectroscopic studies of new ...

Call: PRELUDIUM 24 , Panel: ST11

Principal investigator: Katarzyna Anna Starzak

Politechnika Krakowska im. Tadeusza Kościuszki

Titanium Dioxide in a New Light: Reducing Toxicity and Improving the Photoprotective Properties of TiO2 Through Nanopart...

Call: PRELUDIUM 24 , Panel: NZ7

Principal investigator: Michał Jan Gackowski

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

suPAR in older adults – a new biomarker of inflammageing, sarcopenia, and malnutrition?

Call: PRELUDIUM 24 , Panel: NZ7

Principal investigator: Karolina Agnieszka Dzięcioł

Uniwersytet Medyczny w Łodzi

Hydrothermal surface phosphorylation as the key to the ideal implant – a new generation of implants capable of releasing...

Call: PRELUDIUM 24 , Panel: ST11

Principal investigator: Marcel Jakubowski

Politechnika Poznańska

New methods for the determination of RNA secondary structure, tools towards studies biological activities of RNAs

Call: OPUS 2 , Panel: NZ1

Principal investigator: prof. Ryszard Kierzek

Instytut Chemii Bioorganicznej PAN

New violacein derivatives as candidates for sonodynamic therapy against skin cancer

Call: SONATINA 9 , Panel: NZ7

Principal investigator: dr Daniel Ryszard Ziental

Uniwersytet Przyrodniczy w Poznaniu

A new strategy to fight antibiotic resistance based on hybrids of fluoroquinolones and quaternary ammonium salts

Call: SONATA 20 , Panel: NZ7

Principal investigator: dr Joanna Dagmara Fedorowicz

Gdański Uniwersytet Medyczny

Positioning the aryl hydrocarbon receptor (AhR) as a new target for pharmacotherapy of sporadic Alzheimer disease: verif...

Call: OPUS 28 , Panel: NZ7

Principal investigator: prof. Małgorzata Kajta

Instytut Farmakologii PAN

New Horizons in Cancer Immunotherapy: Blocking LAG-3/FGL1 Interactions

Call: SONATA 20 , Panel: NZ7

Principal investigator: dr Jacek Plewka

Uniwersytet Jagielloński

"Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud...

Call: OPUS 28 , Panel: NZ7

Principal investigator: prof. Gabriel Piotr Nowak

Instytut Farmakologii PAN

A new universal method for the isolation and deep proteomic characterization of extracellular vesicles to study drug res...

Call: PRELUDIUM 23 , Panel: NZ2

Principal investigator: Bianka Świderska

Instytut Biochemii i Biofizyki PAN

Disruption of the posttranslational activation of the translation factor EF-P as a new target for antimicrobial agents.

Call: OPUS 27 , Panel: NZ7

Principal investigator: dr Piotr Wilk

Uniwersytet Jagielloński

Development of novel screening method for identifying xanthine oxidase inhibitors – towards new drug candidates for gout...

Call: PRELUDIUM 23 , Panel: ST4

Principal investigator: Monika Katarzyna Rola

Politechnika Łódzka

Synthesis of new high-performance photoinitiating systems for obtaining DLP-printed three-dimensional polymer aerogel st...

Call: PRELUDIUM 23 , Panel: ST5

Principal investigator: Magdalena Jankowska

Politechnika Krakowska im. Tadeusza Kościuszki

Assessment of the potential of new histidine hybrids and simulation of their metabolism as a potential therapy for neuro...

Call: OPUS 27 , Panel: NZ7

Principal investigator: prof. Paweł Bartosz Szymański

Uniwersytet Medyczny w Łodzi

New functional MOF@hydroxyapatite composites for the treatment of bacterial bone infections

Call: PRELUDIUM 23 , Panel: ST11

Principal investigator: Weronika Bodylska

Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

Development and characterization of multifunctional bioinks based on new, photocurable derivatives of chitosan and poly(...

Call: PRELUDIUM 23 , Panel: ST8

Principal investigator: Aleksandra Anna Sierakowska-Byczek

Politechnika Krakowska im. Tadeusza Kościuszki

Manufacture of a new generation three-dimensional "drug-on-chip" materials with controlled release of active agents dedi...

Call: SONATINA 8 , Panel: ST8

Principal investigator: dr Wiktoria Dominika Tomal

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

Development and evaluation of a new type of wound healing stimulators based on binding loops of the PDGF and VEGF growth...

Call: SONATA 19 , Panel: NZ7

Principal investigator: dr Przemysław Karpowicz

Uniwersytet Gdański, Wydział Chemii

New biomimetic 3D materials for potential use in advanced therapies of bone tissue diseases - 3D BioBone

Call: OPUS 26 , Panel: NZ7

Principal investigator: dr hab. Joanna Krystyna Kolmas

Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

UPLC-MS/MS for methods development for determination of antioxidants and a new generation drugs used in cardiology

Call: PRELUDIUM 2 , Panel: ST4

Principal investigator: dr Sylwia Magiera

Politechnika Śląska, Wydział Chemiczny

Metallacarborane-peptide amphiphiles as a new strategy in the fight against multidrug-resistant Gram-negative bacteria

Call: SONATA 19 , Panel: NZ7

Principal investigator: dr Krzysztof Konrad Fink

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

Call: OPUS 26 , Panel: NZ7

Principal investigator: dr Magdalena Wujak

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

The effect of prolonged treatment with the new antipsychotics brexpiprazole and lumateperone on human liver function usi...

Call: OPUS 26 , Panel: NZ4

Principal investigator: dr Przemysław Jan Danek

Instytut Farmakologii PAN

Synthesis and application of new mixed-mode materials to study the metabolism of drugs used in Poland for the treatment ...

Call: OPUS 26 , Panel: NZ7

Principal investigator: dr hab. Sylwia Studzińska

Uniwersytet Mikołaja Kopernika, Wydział Chemii

A new generation of scaffolds based on curdlan and whey protein isolate obtained by electrospinning for the treatment of...

Call: SONATA 19 , Panel: NZ7

Principal investigator: dr Katarzyna Klimek

Uniwersytet Medyczny w Lublinie

The role of free fatty acid receptors in pathophysiology of the functional gastrointestinal tract disorders: new therapi...

Call: PRELUDIUM BIS 5 , Panel: NZ7

Principal investigator: dr hab. Maciej Stanisław Sałaga

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Unraveling protease activation in stimulated CAR-T cells to identify new biomarkers for assessing their clinical efficac...

Call: OPUS 25 , Panel: NZ7

Principal investigator: dr hab. Małgorzata Firczuk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Do metal nanoparticles affect the biosynthesis of bioactive plant metabolites? - studies on an in vitro culture model of...

Call: OPUS 25 , Panel: NZ7

Principal investigator: dr hab. Agnieszka Szopa

Uniwersytet Jagielloński, Collegium Medicum

Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

Call: PRELUDIUM 22 , Panel: NZ7

Principal investigator: Patryk Pyka

Uniwersytet Jagielloński, Collegium Medicum

Bis(benzosiloxaboroles) as a new class of potential antibiotics - a perspective solution to growing problem of antimicro...

Call: PRELUDIUM 22 , Panel: ST5

Principal investigator: Krzysztof Nowicki

Politechnika Warszawska, Wydział Chemiczny

Computational alchemy and experimental validation: a hybrid approach for designing new antimicrobial peptides

Call: PRELUDIUM 22 , Panel: NZ1

Principal investigator: Piotr Maciej Chyży

Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

Call: SONATA 18 , Panel: NZ7

Principal investigator: dr Urszula Helena Piotrowska

Warszawski Uniwersytet Medyczny

Step beyond classical lipophilicity - modeling of phospholipids affinity using immobilized artificial membranes chromato...

Call: SONATA 18 , Panel: NZ7

Principal investigator: dr hab. Krzesimir Ciura

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

Exploring the unknown drug-like chemical space: new classes of sulfoximine derivatives and their biological activities.

Call: OPUS 24 , Panel: NZ7

Principal investigator: prof. Maciej Filip Dawidowski

Warszawski Uniwersytet Medyczny

Identification of new biofilm-associated genes of Campylobacter jejuni.

Call: PRELUDIUM BIS 4 , Panel: NZ7

Principal investigator: dr hab. Ewa Wałecka-Zacharska

Uniwersytet Przyrodniczy we Wrocławiu, Wydział Medycyny Weterynaryjnej

Brain cytochrome P450 as a new target for the treatment of neurological and psychiatric diseases. Studies with human neu...

Call: OPUS 23 , Panel: NZ7

Principal investigator: prof. Władysława Anna Daniel

Instytut Farmakologii PAN

The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

Call: OPUS 23 , Panel: NZ7

Principal investigator: dr Katarzyna Anna Szczepańska

Instytut Farmakologii PAN

Partial agonists of alpha-2 adrenoceptors as new perspective of the effective and safe in reducting body weight and obes...

Call: OPUS 2 , Panel: NZ7

Principal investigator: dr Magdalena Bogumiła Dudek

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi...

Call: OPUS 23 , Panel: NZ7

Principal investigator: prof. Krzysztof Tomasz Kamiński

Uniwersytet Jagielloński, Collegium Medicum

Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

Call: PRELUDIUM 21 , Panel: NZ7

Principal investigator: Karolina Barbara Przepiórska-Drońska

Instytut Farmakologii PAN

The application of artificial intelligence to the discovery of new natural drugs with mechanisms aimed at lowering free ...

Call: PRELUDIUM 21 , Panel: NZ7

Principal investigator: Maciej Spiegel

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

Electrospun nanofiber-based nanoplatform for delivery of new nutraceutical derivatives to eliminate chemotherapy-induced...

Call: OPUS 22 , Panel: NZ7

Principal investigator: dr hab. Maciej Antoni Wnuk

Uniwersytet Rzeszowski, Collegium Medicum

Biomedical and chemometric assessment of the new analytical platform in the study of endogenous substances as potential ...

Call: OPUS 2 , Panel: NZ7

Principal investigator: dr Lucyna Konieczna

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej